BIO Historical Financial Ratios
| BKYI Stock | USD 0.90 0.02 2.17% |
BIO Key is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0028, PTB Ratio of 1.66 or Days Sales Outstanding of 92.33 will help investors to properly organize and evaluate BIO Key International financial condition quickly.
BIO |
About BIO Financial Ratios Analysis
BIO Key InternationalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BIO Key investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BIO financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BIO Key history.
BIO Key Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing BIO Key International stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BIO Key sales, a figure that is much harder to manipulate than other BIO Key International multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is BIO Key International dividend as a percentage of BIO Key stock price. BIO Key International dividend yield is a measure of BIO Key stock productivity, which can be interpreted as interest rate earned on an BIO Key investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most ratios from BIO Key's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. As of now, BIO Key's Book Value Per Share is increasing as compared to previous years. The BIO Key's current Average Payables is estimated to increase to about 1.3 M, while Price To Sales Ratio is projected to decrease to 0.21.
| 2023 | 2024 (projected) | Dividend Yield | 0.002682 | 0.002817 | Price To Sales Ratio | 0.22 | 0.21 |
BIO Key fundamentals Correlations
Click cells to compare fundamentals
BIO Key Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BIO Key fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 3.14 | 5.83 | 3.37 | 0.68 | 0.22 | 0.21 | |
| Ptb Ratio | (3.11) | 0.81 | 1.11 | 0.67 | 1.58 | 1.66 | |
| Days Sales Outstanding | 38.14 | 116.25 | 78.65 | 81.75 | 61.23 | 92.33 | |
| Book Value Per Share | (23.14) | 77.87 | 35.99 | 15.69 | 1.9 | 1.99 | |
| Free Cash Flow Yield | (0.26) | (0.3) | (0.52) | (1.33) | (2.26) | (2.14) | |
| Operating Cash Flow Per Share | (18.73) | (18.95) | (20.74) | (13.84) | (6.77) | (7.11) | |
| Stock Based Compensation To Revenue | 0.42 | 0.28 | 0.0615 | 0.0553 | 0.0343 | 0.0326 | |
| Capex To Depreciation | 0.0303 | 0.0833 | 0.0817 | 0.15 | 0.001695 | 0.00161 | |
| Pb Ratio | (3.11) | 0.81 | 1.11 | 0.67 | 1.58 | 1.66 | |
| Ev To Sales | 4.34 | 0.1 | 1.9 | 0.62 | 0.2 | 0.19 | |
| Free Cash Flow Per Share | (19.04) | (19.09) | (20.84) | (14.02) | (6.77) | (7.11) | |
| Roic | 221.78 | (0.33) | (0.29) | (1.01) | (6.25) | (5.93) | |
| Inventory Turnover | 5.74 | 2.4 | 0.34 | 0.42 | 14.19 | 13.48 | |
| Net Income Per Share | (148.35) | (52.04) | (10.56) | (23.87) | (15.21) | (15.97) | |
| Days Of Inventory On Hand | 63.64 | 151.98 | 1.1K | 865.16 | 25.73 | 24.44 | |
| Payables Turnover | 2.68 | 3.26 | 3.91 | 1.84 | 4.81 | 5.05 | |
| Research And Ddevelopement To Revenue | 0.35 | 0.59 | 0.49 | 0.46 | 0.31 | 0.29 | |
| Capex To Revenue | 0.0134 | 0.0125 | 0.008217 | 0.0117 | 1.29E-4 | 1.23E-4 | |
| Cash Per Share | 5.99 | 67.03 | 17.91 | 5.86 | 0.91 | 0.87 | |
| Pocfratio | (3.84) | (3.34) | (1.92) | (0.76) | (0.44) | (0.47) | |
| Interest Coverage | (6.14) | (1.12) | (277.88) | (323.55) | (40.44) | (42.46) | |
| Capex To Operating Cash Flow | (0.0165) | (0.007185) | (0.004681) | (0.0132) | (2.64E-4) | (2.77E-4) | |
| Pfcf Ratio | (3.78) | (3.32) | (1.91) | (0.75) | (0.44) | (0.47) | |
| Days Payables Outstanding | 136.33 | 112.12 | 93.33 | 198.34 | 75.96 | 72.16 | |
| Income Quality | 0.13 | 0.51 | 1.77 | 0.52 | 0.45 | 0.42 | |
| Roe | 6.41 | (0.67) | (0.29) | (1.52) | (8.01) | (7.61) | |
| Ev To Operating Cash Flow | (5.32) | (0.0574) | (1.08) | (0.69) | (0.4) | (0.42) | |
| Pe Ratio | (0.49) | (1.22) | (3.77) | (0.44) | (0.2) | (0.19) | |
| Return On Tangible Assets | (6.46) | (0.69) | (0.3) | (1.06) | (2.74) | (2.88) | |
| Ev To Free Cash Flow | (5.24) | (0.057) | (1.08) | (0.69) | (0.4) | (0.42) | |
| Earnings Yield | (2.06) | (0.82) | (0.27) | (2.27) | (5.07) | (4.82) | |
| Intangibles To Total Assets | 0.6 | 0.0914 | 0.13 | 0.15 | 0.31 | 0.37 | |
| Net Debt To E B I T D A | (0.22) | 3.32 | 1.65 | 0.0364 | 0.0186 | 0.0177 | |
| Tangible Book Value Per Share | (25.45) | 67.01 | 29.96 | 11.68 | (0.61) | (0.65) | |
| Receivables Turnover | 9.57 | 3.14 | 4.64 | 4.47 | 5.96 | 3.38 |
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.